Department of Pediatric Rheumatology, CeReMAIA, CHU Bicêtre, Assistance Publique-Hôpitaux de Paris, Université de Paris Saclay, 78 Rue du Général Leclerc, 94270 Le Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.
Paediatr Drugs. 2024 Jan;26(1):31-47. doi: 10.1007/s40272-023-00596-5. Epub 2023 Oct 4.
Uveitis in children accounts for 5-10% of all cases. The causes vary considerably. Classically, uveitis is distinguished according to its infectious or inflammatory origin and whether it is part of a systemic disease or represents an isolated ocular disease. It is important to highlight the specificity of certain etiologies among children such as juvenile idiopathic arthritis. The development of visual function can potentially be hindered by amblyopia (children aged < 7 years), in addition to the usual complications (synechiae, macular edema) seen in adult patients. Moreover, the presentation of uveitis in children is often "silent" with few warning signs and few functional complaints from young children, which frequently leads to a substantial diagnostic delay. The diagnostic approach is guided by the presentation of the uveitis, which can be characterized by its location, and corresponds to the initial and main site of intraocular inflammation; its presentation, whether acute or chronic, granulomatous or not; and the response to treatment. Pediatricians have an important role to play and must be aware of the various presentations and etiologies of uveitis in children. Juvenile idiopathic arthritis is the most common etiology of pediatric non-infectious uveitis, but other causes must be recognized. Promptly initiated treatment before complications arise requires early diagnosis, recognition, and treatment. Any dependence on prolonged local corticosteroid therapy justifies discussing the introduction of a corticosteroid-sparing treatment considering the risk to develop corticoid-induced glaucoma and cataracts. Systemic corticosteroid therapy can be required for urgent control of inflammation in the case of severe uveitis. Long-lasting immunosuppressive treatment and biotherapies are most often prescribed at the same time to reinforce treatment efficacy and to prevent relapse and corticosteroid dependency. We review the different causes of uveitis, excluding infection, and the diagnostic and therapeutic management aimed at limiting the risk of irreversible sequelae.
儿童的葡萄膜炎占所有病例的 5-10%。病因差异很大。经典地,葡萄膜炎根据其感染或炎症来源以及是否是系统性疾病的一部分或代表孤立的眼部疾病进行区分。重要的是要强调儿童中某些病因的特异性,例如幼年特发性关节炎。除了成年患者常见的并发症(粘连、黄斑水肿)外,弱视(<7 岁的儿童)可能会阻碍视力功能的发展。此外,儿童葡萄膜炎的表现通常是“沉默”的,年幼的儿童很少有警告迹象和功能投诉,这经常导致大量的诊断延误。诊断方法由葡萄膜炎的表现指导,其可以通过其位置进行特征化,并且对应于眼内炎症的初始和主要部位;其表现,无论是急性还是慢性,是否为肉芽肿性;以及对治疗的反应。儿科医生发挥着重要作用,必须了解儿童葡萄膜炎的各种表现和病因。幼年特发性关节炎是儿童非感染性葡萄膜炎最常见的病因,但必须认识到其他原因。在出现并发症之前及时开始治疗需要早期诊断、识别和治疗。任何对长期局部皮质类固醇治疗的依赖都证明了考虑到发展皮质类固醇诱导性青光眼和白内障的风险,引入皮质类固醇节约治疗是合理的。在严重葡萄膜炎的情况下,全身皮质类固醇治疗可能需要紧急控制炎症。长效免疫抑制治疗和生物疗法通常同时开处方,以增强治疗效果并预防复发和皮质类固醇依赖性。我们回顾了排除感染的葡萄膜炎的不同病因以及旨在限制不可逆转后遗症风险的诊断和治疗管理。